With an IPO raise of $625 million, Kailera Therapeutics now holds the new record for the largest public market debut.
Deep Learning with Yacine on MSNOpinion
RLM without recursion: Is it better in reinforcement learning?
A conceptual breakdown exploring whether removing recursion improves reinforcement learning models, focusing on stability, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results